I-Mab Appoints Dr. Sean Cao to Board of Directors
Ticker: NBP · Form: 6-K · Filed: May 30, 2025 · CIK: 1778016
Sentiment: neutral
Topics: board-appointment, governance
TL;DR
I-Mab adds Dr. Sean Cao to its board, effective immediately.
AI Summary
On May 28, 2025, I-Mab appointed Dr. Sean Cao as an independent member of its Board of Directors. Dr. Cao will also serve on the Audit Committee and the Compensation Committee of the Board. He currently holds the position of Operating Partner.
Why It Matters
The addition of a new independent director can signal a shift in governance or strategic direction for the company.
Risk Assessment
Risk Level: low — This filing is a routine corporate announcement regarding a board appointment and does not involve financial performance or significant operational changes.
Key Players & Entities
- I-Mab (company) — The company making the announcement.
- Dr. Sean Cao (person) — Newly appointed independent director.
- May 28, 2025 (date) — Effective date of the board appointment.
FAQ
Who is Dr. Sean Cao and what is his current role?
Dr. Sean Cao is the newly appointed independent member of I-Mab's Board of Directors and currently serves as an Operating Partner.
When was Dr. Sean Cao appointed to the board?
Dr. Sean Cao was appointed to the board of directors of I-Mab effective immediately on May 28, 2025.
Which committees will Dr. Sean Cao serve on?
Dr. Sean Cao has been appointed as a member of the Audit Committee and the Compensation Committee of the Board.
What is the company's filing number?
The Commission File Number for I-Mab is 001-39173.
What type of form is this filing?
This filing is a Form 6-K, Report of Foreign Private Issuer.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 30, 2025 by Dr. Sean Cao regarding I-Mab (NBP).